Using the MProt-DPO framework, scientists created synthetic versions of malate dehydrogenase that preserve the protein’s critical structure and key binding areas. Harnessing the power of artificial ...

Cancer immunotherapy, especially using T cells, is showing a lot of promise in treating blood cancers. Bioengineered T cells, especially those equipped with chimeric antigen receptors (CAR-T cells), ...

Jue Wang (left) is a research scientist and one of the scientific leads of the protein design team at Google DeepMind (London, UK). Before joining DeepMind, Jue was a postdoc with David Baker ...

BOSTON--(BUSINESS WIRE)--AI Proteins, Inc., a biotechnology company that utilizes computational de novo protein design to create therapeutic miniproteins, today announced that it has entered a ...

A new paper published today in Cell highlights how researchers have leveraged AI-based computational protein design to create a novel synthetic ligand that activates the Notch signaling pathway, a key ...

One of those Baker lab spin-offs is Vilya, which uses computational protein design to create membrane- permeable macrocyclic drugs. When the biotech venture capital firm Arch Venture Partners met the ...

A paper published in Cell highlights how researchers have leveraged AI-based computational protein design to create a novel synthetic ligand that activates the Notch signaling pathway, a key driver in ...

The ability to alter proteins to refine control over binding affinity and specificity can create tailored therapeutics with reduced side effects, highly sensitive diagnostic tools, efficient ...

Many of the food industry’s most persistent problems exist not in the realm of business and economics – scaling, costs of materials and the like – but in nature itself. Crops, which the food industry ...